Current status and new developments in Peyronie's disease: Medical, minimally invasive and surgical treatment options - Abstract

Tulane University, Health Sciences Center, Department of Urology, 1430 Tulane Avenue, SL-42, New Orleans, LA 70112, USA.


Peyronie's disease (PD) is a wound-healing disorder of the tunica albuginea of the penis which affects 3 - 9% of adult males. Clinically, any combination of plaque formation, penile pain, angulation and erectile dysfunction may appear. This condition may progress, stabilize or, uncommonly, regress during the initial acute phase (6 - 18 months).

Information regarding this review was searched in PubMed until August 2010. Vitamin E, paraaminobenzoate and colchicine are sparingly employed oral medical therapies. Intralesional injections as a minimally invasive therapy for PD includes injection with verapamil, interferon-α-2b, and collagenase. Men suffering with PD who have significant penile deformity precluding successful coitus can be appraised for surgical correction. Surgery is considered the gold standard and includes plication, incision and grafting- or penile-prosthesis-related procedures.

This paper provides a broad overview of the subject of PD, available nonsurgical options and surgical approaches that will aid in the routine clinical diagnosis and management of PD. Increased public and medical awareness of PD prevalance, presentation, diagnosis and treatment options will serve well the large population of men who suffer in silence with this common condition.

Written by:
Gur S, Limin M, Hellstrom WJ.   Are you the author?

Reference: Expert Opin Pharmacother. 2011 Mar 15. Epub ahead of print.
doi: 10.1517/14656566.2011.544252

PubMed Abstract
PMID: 21405946 Peyronie's Disease Section